The Executional Excellence issue of Perspective magazine is live
|23rd May 2017
Blue Latitude Health has spent 14 years building a truly world-class creative marketing consultancy. Combining the best of consultancy and agency to solve the most complex of healthcare challenges at a brand, portfolio and organisational level.
What drives us at BLH is the opportunity to make a real difference – and for our clients, that difference is measured both in customer outcomes and commercial outcomes. Creating work that stands out is important, but creating work that delivers results is imperative. In this edition, we explore topics around the ‘executional excellence’ theme – creating work that works.
Read more about:
- How to plan and execute the perfect congress experience
- How to find that global sweet spot - international creative work that works
- What an EMEA Marketing Lead at Janssen looks for in an exceptional creative campaign
- How global organisations can improve the localisation of digital services in pharma
- How we created a properly integrated full-service global team by baking in creative services to our consultancy approach.
Click the button below to enter your details and receive your free digital copy.
Five key trends in precision and personalised healthcare
|5th December 2019
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of these exciting innovations.
Why aren't doctors using digital therapeutics?
|29th November 2019
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.
Launch Excellence 2020
|18th November 2019
In this publication, we explore what makes a successful pharma launch from developing insight that drives behaviour change to lean launches and multi-indication launches, as well as an evaluation of the CAR-T market.